BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3811919)

  • 1. The prognostic significance of the monoclonal antibody III D 5 to human milk fat globule antigen in breast cancer.
    Helle M
    Acta Pathol Microbiol Immunol Scand A; 1986 Nov; 94(6):375-80. PubMed ID: 3811919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human milk fat globule antigen III D 5, steroid receptors and histopathologic parameters in breast cancer.
    Helle M; Helin H; Antonen J; Krohn K
    APMIS; 1988 May; 96(5):415-20. PubMed ID: 2837254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer.
    Berry N; Jones DB; Smallwood J; Taylor I; Kirkham N; Taylor-Papadimitriou J
    Br J Cancer; 1985 Feb; 51(2):179-86. PubMed ID: 2578285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas.
    Wilkinson MJ; Howell A; Harris M; Taylor-Papadimitriou J; Swindell R; Sellwood RA
    Int J Cancer; 1984 Mar; 33(3):299-304. PubMed ID: 6365800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial markers for paraffin-embedded human tissues. Immunohistochemistry with monoclonal antibodies against milk fat globule antigens.
    Zotter S; Lossnitzer A; Kunze KD; Müller M; Hilkens J; Hilgers J; Hageman P
    Virchows Arch A Pathol Anat Histopathol; 1985; 406(2):237-51. PubMed ID: 2988188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator.
    Ellis IO; Hinton CP; MacNay J; Elston CW; Robins A; Owainati AA; Blamey RW; Baldwin RW; Ferry B
    Br Med J (Clin Res Ed); 1985 Mar; 290(6472):881-3. PubMed ID: 3919829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
    Siitonen SM; Kallioniemi OP; Isola JJ
    Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical reactivity of monoclonal antibodies to human milk fat globule with breast carcinoma and with other normal and neoplastic tissues.
    Helle M; Krohn K
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):43-51. PubMed ID: 3515847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental immunotherapy of human breast carcinomas implanted in nude mice with a mixture of monoclonal antibodies against human milk fat globule components.
    Ceriani RL; Blank EW; Peterson JA
    Cancer Res; 1987 Jan; 47(2):532-40. PubMed ID: 3791239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.
    Travis A; Pinder SE; Robertson JF; Bell JA; Wencyk P; Gullick WJ; Nicholson RI; Poller DN; Blamey RW; Elston CW; Ellis IO
    Br J Cancer; 1996 Jul; 74(2):229-33. PubMed ID: 8688326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of monoclonal antibodies to human milk-fat globule membrane antigens, with special reference to a precipitable secretory product of breast and ovarian carcinomas.
    Krohn K; Ashorn R; Helle M
    Tumour Biol; 1985; 6(1):13-23. PubMed ID: 3927470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10.
    Pancino GF; Le Doussal V; Mortada MH; Berthon P; Osinaga E; Calvo F; Roseto A
    Cancer Res; 1989 Dec; 49(24 Pt 1):7078-85. PubMed ID: 2555058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial membrane antigen--a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies.
    Pinkus GS; Kurtin PJ
    Hum Pathol; 1985 Sep; 16(9):929-40. PubMed ID: 2993153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of cathepsin D, proliferating cell nuclear antigen and epidermal growth factor receptor in human breast carcinoma analysed by computer image analyser: correlation with histological grade and metastatic behaviour.
    Okamura K; Kobayashi I; Matsuo K; Kiyoshima T; Yamamoto K; Miyoshi A; Sakai H
    Histopathology; 1997 Dec; 31(6):540-8. PubMed ID: 9447385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of a monoclonal antibody recognizing an estrogen receptor regulated glycoprotein in relation to lectin histochemistry in breast cancer.
    Helle M; Krohn K
    Virchows Arch A Pathol Anat Histopathol; 1986; 410(1):23-9. PubMed ID: 3097949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of a membrane glycoprotein in benign fibrocystic disease and infiltrating duct carcinomas of the human breast with the use of a monoclonal antibody to guinea pig milk fat globule membrane.
    Greenwalt DE; Johnson VG; Kuhajda FP; Eggleston JC; Mather IH
    Am J Pathol; 1985 Mar; 118(3):351-9. PubMed ID: 2579563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up.
    Thor AD; Schwartz LH; Koerner FC; Edgerton SM; Skates SJ; Yin S; McKenzie SJ; Panicali DL; Marks PJ; Fingert HJ
    Cancer Res; 1989 Dec; 49(24 Pt 1):7147-52. PubMed ID: 2573426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of immunoreactivity with monoclonal antibody NCRC 11 in breast carcinoma.
    Ellis IO; Bell J; Todd JM; Williams M; Dowle C; Robins AR; Elston CW; Blamey RW; Baldwin RW
    Br J Cancer; 1987 Sep; 56(3):295-9. PubMed ID: 3663477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study.
    Hayes DF; Mesa-Tejada R; Papsidero LD; Croghan GA; Korzun AH; Norton L; Wood W; Strauchen JA; Grimes M; Weiss RB
    J Clin Oncol; 1991 Jul; 9(7):1113-23. PubMed ID: 2045853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.
    Galea MH; Athanassiou E; Bell J; Dilks B; Robertson JF; Elston CW; Blamey RW; Ellis IO
    J Pathol; 1991 Nov; 165(3):221-7. PubMed ID: 1722247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.